Factors such as inactivity, excess weight, and certain ethnic backgrounds increase the risk of developing type 2 diabetes.

Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

In this randomized clinical trial of adults with type 2 diabetes (T2D), the artificial intelligence-based insulin clinical ...

Sana Biotechnology, Inc. (NASDAQ:SANA) ranks among the best CRISPR stocks to buy. On June 24, Citizens JMP reaffirmed its $5 ...

Measuring insulin resistance with a simple, low-cost blood test can help predict the pace of cognitive decline in patients ...

Humulin N is a type of insulin used to treat type 1 and type 2 diabetes. Get the facts and see if this drug may work for you.

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

In a small cell therapy trial, 10 out of 12 people with type 1 diabetes no longer needed supplemental insulin, even a year after treatment.

After a one-year follow-up, 10 of 12 patients given the islet cell therapy zimislecel no longer required insulin. Vertex ...

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

An experimental once-weekly insulin known as efsitora has shown comparable effectiveness to daily insulin regimens in ...

Once-weekly efsitora vs once-daily degludec was associated with comparable glycemic control outcomes and improved ...